Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

5.33

+0.19 (3.70%)

At close: Apr 17, 2026, 4:00 PM EDT

5.34

+0.01 (0.27%)

After-hours: Apr 17, 2026, 4:36 PM EDT

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	628.11	879.52	526.42	339.15	438.68
Cash & Short-Term Investments	628.11	879.52	526.42	339.15	438.68
Cash Growth	-28.59%	67.07%	55.22%	-22.69%	222.58%
Accounts Receivable	-	-	-	2.05	1
Other Receivables	35.59	35.65	24.04	19.16	10.91
Receivables	35.59	35.65	24.04	21.21	11.91
Prepaid Expenses	19.18	13.43	11.41	9.02	7.97
Total Current Assets	682.89	928.61	561.87	369.38	458.56
Property, Plant & Equipment	21.91	17.19	27.68	32.77	17.79
Other Long-Term Assets	12.81	11.07	5.79	8.46	3.45
Total Assets	717.6	956.87	595.34	410.61	479.79
Accounts Payable	9.67	15.79	13.05	6.47	2.72
Accrued Expenses	41.46	35.45	26.38	21.86	11.29
Current Portion of Leases	2.76	5.5	4.88	3.13	2.38
Current Unearned Revenue	2.96	10.19	24.98	20.42	19.27
Other Current Liabilities	0.14	0.3	0.26	1.47	0.57
Total Current Liabilities	56.98	67.23	69.54	53.34	36.24
Long-Term Debt	-	-	30.7	30.32	29.87
Long-Term Leases	14.1	3.99	9.38	10.89	12.08
Long-Term Unearned Revenue	35.51	91.47	110.22	41.46	52.07
Other Long-Term Liabilities	1.03	1.12	4.58	3.83	3.28
Total Liabilities	107.62	163.81	224.41	139.83	133.54
Common Stock	0.89	0.89	0.55	0.39	0.38
Additional Paid-In Capital	1,512	1,473	883.45	601.11	567.64
Retained Earnings	-899.75	-680.79	-511.76	-331.1	-218.38
Comprehensive Income & Other	-3.51	0.12	-1.3	0.39	-3.39
Total Common Equity	609.98	793.06	370.93	270.78	346.25
Shareholders' Equity	609.98	793.06	370.93	270.78	346.25
Total Liabilities & Equity	717.6	956.87	595.34	410.61	479.79
Total Debt	16.85	9.49	44.96	44.33	44.34
Net Cash (Debt)	611.26	870.03	481.47	294.83	394.34
Net Cash Growth	-29.74%	80.70%	63.30%	-25.24%	228.03%
Net Cash Per Share	8.82	14.95	13.53	9.94	15.73
Filing Date Shares Outstanding	69.71	69.2	42.59	30.02	29.6
Total Common Shares Outstanding	69.37	69.06	42.43	29.87	29.58
Working Capital	625.9	861.38	492.33	316.04	422.32
Book Value Per Share	8.79	11.48	8.74	9.06	11.71
Tangible Book Value	609.98	793.06	370.93	270.78	346.25
Tangible Book Value Per Share	8.79	11.48	8.74	9.06	11.71
Machinery	19.06	16.53	16.91	16.24	7.11
Leasehold Improvements	12.03	10.9	11	10.74	0.81

Updated Mar 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q